Filana Therapeutics Inc (FLNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Sales | 5,080 | 0 | 0 | 0 | 0 |
| Gross Profit | 5,080 | N/A | 0 | 0 | 0 |
| Operating Expenses | 37,797 | 38,961 | 2,490 | 1,410 | 1,460 |
| Operating Income | -32,717 | -38,961 | -2,490 | -1,410 | -1,460 |
| Interest Expense | 0 | 0 | 10 | 20 | 9 |
| Other Income | 2,047 | 1,185 | -10 | -2,990 | -27,021 |
| Pre-tax Income | -30,670 | -37,776 | -2,510 | -4,420 | -28,490 |
| Net Income Continuous | -30,670 | -37,776 | -2,517 | -4,425 | -28,490 |
| Net Income | $-30,670 | $-37,776 | $-2,510 | $-4,420 | $-28,490 |
| EPS Basic Total Ops | -4.90 | -7.07 | -0.11 | -0.31 | -2.62 |
| EPS Basic Continuous Ops | -4.90 | -7.09 | -0.11 | -0.31 | -2.62 |
| EPS Diluted Total Ops | -4.90 | -7.07 | -0.11 | -0.31 | N/A |
| EPS Diluted Continuous Ops | -4.90 | -7.09 | -0.11 | -0.31 | N/A |
| EBITDA(a) | $-32,349 | $-38,578 | $-2,440 | $-1,340 | $-1,420 |